CDEK
← All drugs Report issue

centella asiatica

Botanicalexperimental

Centella asiatica, commonly known as Indian pennywort, Asiatic pennywort, spadeleaf, coinwort or gotu kola, is a herbaceous, perennial plant in the flowering plant family Apiaceae. It is native to tropical regions of Africa, Asia, Australia, and islands in the western Pacific Ocean. It is consumed as a culinary vegetable and is used in traditional medicine. — Wikipedia

Clinical trial activity

22 trials · 26 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
3
Phase 3
3
Phase 4
8

Earliest trial started Dec 1, 2008 (NCT00709514)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • centella asiatica
  • dcb-wh1
  • gotukola

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06850935N/ASep 4, 2024Hung Kaung University
NCT06472791N/ASep 1, 2024National College of Natural Medicine
NCT06566508Phase 2/Phase 3 (Phase 3)Nov 20, 2023Mansoura University
NCT05937529N/ASep 27, 2023L'Oreal, University of Copenhagen
NCT05438251Phase 4Sep 1, 2022China Medical University
NCT05317442Phase 4Mar 30, 2022Kaohsiung Medical University, Taipei Medical University
NCT05271708Phase 4Jan 5, 2022Government of Taiwan
NCT05338463Phase 4Dec 1, 2021Cathay General Hospital
NCT04962139Phase 3Aug 10, 2021Oneness Biotech Co., Ltd.
NCT05322525Phase 4Jun 23, 2021Taipei Medical University, Taipei Veteran General hospital
NCT04886882Early Phase 1 (Phase 1)Mar 22, 2021Basaksehir Cam & Sakura Şehir Hospital, Istanbul Kent University
NCT04945161N/AMar 2, 2021Oneness Biotech Co., Ltd.
NCT04669119Phase 4Dec 31, 2020University of Bari
NCT03937908Early Phase 1 (Phase 1)Aug 1, 2019National Center for Complementary and Integrative Health (NCCIH), Oregon Health and Science University
NCT03929250Early Phase 1 (Phase 1)Jul 1, 2019Oregon Health and Science University
NCT03815305Phase 4Jul 30, 2018University of Indonesia
NCT03569930Phase 4May 1, 2018University of Roma La Sapienza
NCT07071389N/AJan 8, 2018Lo.Li. Pharma, Ltd.
NCT02827305Phase 1Aug 1, 2015Sri Hasanamba Dental College and Hospital
NCT05017467Early Phase 1 (Phase 1)Jan 1, 2011Istanbul Medipol University, Konya Numune Hospital
Showing 20 of 22 trials
Page 1 / 2

Organizations

Research & Development (26)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Oneness Biotech Co., Ltd.For profit2222021
Oregon Health and Science UniversityAcademic/Hospital2212019
Taipei Medical UniversityAcademic/Hospital2112021
Taipei Veteran General hospitalGovernment2022008
Basaksehir Cam & Sakura Şehir HospitalAcademic/Hospital1112021
Cathay General HospitalAcademic/Hospital1112021
China Medical UniversityAcademic/Hospital1012022
Government of TaiwanGovernment1112022
Hung Kaung UniversityAcademic/Hospital1112024
Istanbul Kent UniversityAcademic/Hospital1012021
Istanbul Medipol UniversityAcademic/Hospital1012011
Kaohsiung Medical UniversityAcademic/Hospital1012022
Konya Numune HospitalAcademic/Hospital1112011
LGFor profit1112009
Lo.Li. Pharma, Ltd.For profit1112018
L'OrealFor profit1012023
Mansoura UniversityAcademic/Hospital1112023
Microbio Co LtdFor profit1112008
National Center for Complementary and Integrative Health (NCCIH)Government1012019
National College of Natural MedicineAcademic/Hospital1112024
26 organizations
Page 1 / 2